Lupin informs about press release

14 Jun 2024 Evaluate
Lupin has informed that it enclosed a Press Release regarding completion of an inspection by U.S. FDA of the Company’s Injectable facility in Nagpur, India. The inspection of the facility was carried out from June 10 to June 13, 2024, and concluded with zero 483 observations. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2314.85 -42.00 (-1.78%)
13-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.50
Dr. Reddys Lab 1293.00
Cipla 1314.10
Zydus Lifesciences 906.00
Lupin 2314.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×